Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders

Details for Australian Patent Application No. 2003233067 (hide)

International Classifications

Event Publications

28 August 2003 Complete Application Filed

Priority application(s): 02100417.1 25.04.02 EP

18 December 2003 Application Open to Public Inspection

Published as AU-B-2003233067

25 October 2007 Assignment before Grant

Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

8 January 2009 Application Accepted

Published as AU-B-2003233067

23 April 2009 Alteration of Name

The name of the applicant has been altered to Merck Serono SA

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.